ArticlePolymers2021
Thermally Activated Delayed Fluorescence in Commercially Available Materials for Solution-Process Exciplex OLEDs.
Article in Polymers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Synthesis and applications of NPB derivatives as hole transport molecules for performance manipulation of fiber-based triboelectric nanogenerators.Scientific reports · 2025Article
- Overview on the Thermally Activated Delayed Fluorescence and Mechanochromic Materials: Bridging Efficiency and Versatility in LECs and OLEDs.Materials (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Organic light-emitting diodes (OLEDs) have developed rapidly in recent years. Thermally activated delayed fluorescent (TADF) molecules open a path to increase exciton collection efficiency from 25% to 100%, and the solution process provides an alternative technology to achieve lower cost OLEDs more easily. To develop commercial materials as exciplex hosts for high-performance and solution-processed OLEDs, we attempted to use 4,4'-cyclohexylidenebis[N,N-bis(4-methylphenyl)benzenamine (TAPC), poly(9-vinylcarbazole) (PVK), N,N'-Di(1-naphthyl)-N,N'-diphenyl-(1,1'-biphenyl)-4,4'-diamine (NPB), and poly(N,N'-bis-4-butylphenyl-N,N'-bisphenyl)benzidine (Poly-TPD) as the donors and 2,4,6-tris[3-(diphenylphosphinyl)phenyl]-1,3,5-triazine (POT2T) as the acceptor to obtain the TADF effect. All donors and the acceptor were purchased from chemical suppliers. Our work shows that excellent TADF properties and high-efficiency exciplex OLEDs with low turn-on voltage and high luminance can be achieved with a simple combination of commercial materials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.